Xbrane Biopharma Ab operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Xbrane Biopharma Ab with three other
companies in this sector in Sweden:
sales of 20.69 million Swedish Kronor [US$2.25 million]
(22.87 million Swedish Kronor [US$2.48 million]
of which 100%
was Medical Research Tools), and
Active Biotech AB
(20.25 million Swedish Kronor [US$2.20 million]
of which 74%
was Rental revenues).
Sales increased substantially in 2017:
Xbrane Biopharma Ab reported sales of SEK 20.77 million (US$2.26 million)
December of 2017.
increase of 734.1%
versus 2016, when the company's sales were SEK 2.49 million.
This was the fourth straight year of sales growth at Xbrane Biopharma Ab.